Cirrhosis clinical trials in California
8 studies for Cirrhosis are looking for participants at sites in California.
Cities in California
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Hope Clinical Research, Canoga Park
- Velocity Clinical Research-Chula Vista, Chula Vista
- Southern California Research Center, Coronado
- and 21 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06632444A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
- Southern California Research Center, Coronado
- Velocity Clinical Research, San Diego, La Mesa
- Kaiser Permanente - Los Angeles Medical Center, Los Angeles
- and 1 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 30, 2026 · NCT07325526Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- University of California San Diego NAFLD Research Center, La Jolla
- Keck Medical Center of USC, Los Angeles
- LAC + USC Medical Center, Los Angeles
- and 2 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 28, 2026 · NCT05832229National Liver Cancer Screening Trial
- University of Southern California, Los Angeles
- Stanford University, Redwood City
- Kaiser Permanente, Roseville
- and 1 more
RecruitingPhase 4
Ages 18 to 85 · All sexes · Updated Sep 25, 2026 · NCT06084234Multi-analyte Blood Test Clinical Trial
- Gastroenterology and Liver Institute, Escondido
- Providence Facey Medical Foundation, Mission Hills
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT05199259Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
- Cedars-Sinai Comprehensive Transplant Center, Los Angeles
RecruitingObservational study
Ages 18 to 80 · All sexes · Updated Oct 20, 2025 · NCT04613921Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
- Southern California Research Center, Coronado
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Sep 5, 2025 · NCT05490888Danazol for Treatment of Cytopenias in Patients With Cirrhosis
- Keck Hosital of USC, Los Angeles
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 11, 2025 · NCT04873102From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.